Identification of novel pathogenic variants of CUBN in patients with isolated proteinuria

Huihui Yang,Lanfen He,Hongjian Gong,Chunhui Wan,Juanjuan Ding,Panli Liao,Xiaowen Wang
DOI: https://doi.org/10.1002/mgg3.2353
2024-03-16
Molecular Genetics & Genomic Medicine
Abstract:Characterization of CUBN mutations. (A) Clinical characteristics of the studied patients. NA: not available. (B) Sanger sequencing of RT‐PCR product showed CUBN mRNA exon 44 skipping in case 1, generating early stop codon. (C) Immunohistochemical images showed that full‐length cubilin was absent in the renal proximal tubules of patient 1 with an antibody against cubilin AA3350‐3550. (D) Minigene of HEK293T cells untransfected, transfected by pcDNA3.1‐CUBN wild type (WT), and c.10764+1G>A (MT) showed retention of the first four nucleotides of intron 66 due to the above point mutation. (E) Schematic diagram of the cubilin domains, the location of missense mutations, and truncated sites of splicing mutations. The blue font indicates the reported site, and the black is novel. (F) Structural modeling of CUBN missense variants. Background Although proteinuria is long recognized as an independent risk factor for progressive chronic kidney diseases, not all forms of proteinuria are detrimental to kidney function, one of which is isolated proteinuria caused by cubilin (CUBN)‐specific mutations. CUBN encodes an endocytic receptor, initially found to be responsible for the Imerslund–Gräsbeck syndrome (IGS; OMIM #261100) characterized by a combined phenotype of megaloblastic anemia and proteinuria. Methods After analyzing their clinical and pathological characterizations, next‐generation sequencing for renal disease genes or whole‐exome sequencing (WES) was performed on four patients with non‐progressive isolated proteinuria. CUBN biallelic pathogenic variants were identified and further analyzed by cDNA‐PCR sequencing, immunohistochemistry, minigene assay, and multiple in silico prediction tools, including 3D protein modeling. Results Here, we present four patients with isolated proteinuria caused by CUBN C‐terminal biallelic pathogenic variants, all of which showed no typical IGS symptoms, such as anemia and vitamin B12 deficiency. Their urine protein levels fluctuated between +~++ and estimated glomerular filtration rate (eGFR) were normal or slightly higher. Mild mesangial hypercellularity was found in three children's renal biopsies. A homozygous splice‐site variant of CUBN (c.6821+3 (IVS44) A>G) was proven to result in the exon 44 skipping and premature translation termination by cDNA sequencing and immunohistochemistry. Compound heterozygous mutations were identified among the other three children, including another novel splice‐site variant (c.10764+1 (IVS66) G>A) causing the retention of first 4 nucleotides in intron 66 by minigene assay, two unreported missense mutations (c.4907G>A (p.R1636Q); c. 9095 A>G (p.Y3032C)), and two reported missense mutations in China (c.8938G>A (p.D2980N); c. 9287T>C (p.L3096P)), locating behind the vitamin B12‐binding domain, affecting CUB11, CUB16, CUB22, CUB23, and CUB27 domains, respectively. Conclusion These results demonstrate that above CUBN mutations may cause non‐progressive and isolated proteinuria, expanding the variant spectrum of CUBN and benefiting our understanding of proteinuria and renal function.
genetics & heredity
What problem does this paper attempt to address?